ICU Medical, Inc. Extends Two Distribution Agreements With Hospira, Inc.
22 Dezembro 2011 - 3:06PM
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development,
manufacture and sale of innovative medical technologies used in
I.V. therapy, oncology and critical care applications, today
announced that it has extended two primary distribution agreements
with Hospira, Inc. (NYSE:HSP), through December 31, 2018.
Under the co-promotion and distribution agreement, which was
initially signed in February 2001, ICU Medical manufactures all new
custom infusion sets for sale by Hospira, and the two companies
jointly promote the products under the name SetSource®. Under the
supply and distribution agreement, which was initially signed in
April 1995, Hospira purchases primarily CLAVE® and oncology
products. The agreements maintain the current Hospira rights to
distribute ICU Medical products worldwide with terms that
previously extended to 2014.
Dr. George Lopez, founder and CEO of ICU Medical, Inc.,
commented, "We are very pleased to extend our two major
distribution agreements with Hospira, which demonstrates their
trust and confidence in our product offerings. Hospira has been our
valuable partner for many years and we look forward to continuing
our relationship and providing customers with access to our
innovative CLAVE, oncology products, custom infusion sets and other
products worldwide."
Financial terms of the agreements were not disclosed.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells
innovative medical technologies used in I.V. therapy, oncology, and
critical care applications. ICU Medical's products improve patient
outcomes by helping prevent bloodstream infections, protecting
healthcare workers from exposure to infectious diseases or
hazardous drugs and monitor continuous cardiac output of critical
care patients. The Company's complete product line includes custom
I.V. systems, closed delivery systems for hazardous drugs,
needleless I.V. connectors, catheters and cardiac monitoring
systems. ICU Medical is headquartered in San Clemente, California.
For more information, visit the Company's website at
www.icumed.com.
About Hospira
Hospira, Inc. (NYSE:HSP), is the world's leading provider of
injectable drugs and infusion technologies. Through its broad,
integrated portfolio, Hospira is uniquely positioned to Advance
Wellness™ by improving patient and caregiver safety while reducing
healthcare costs. The company is headquartered in Lake Forest,
Ill., and has approximately 14,000 employees. Learn more at
www.hospira.com.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Such statements contain words such as "will," "expect,"
"believe," "could," "would," "estimate," "continue," "build,"
"expand" or the negative thereof or comparable terminology, and may
include (without limitation) information regarding the Company's
expectations, goals or intentions regarding the future, including,
but not limited to, statements regarding the Company's
expectations regarding its relationship with Hospira and
customer access to the Company's products. These
forward-looking statements are based on Management's current
expectations, estimates, forecasts and projections about the
Company and assumptions Management believes are reasonable, all of
which are subject to risks and uncertainties that could cause
actual results and events to differ materially from those stated in
the forward-looking statements. These risks and uncertainties
include, but are not limited to, decreased demand for the Company's
products, increased competition from competitors, lack of continued
growth or improving efficiencies and unexpected changes in the
Company's arrangements with its largest customers. Future results
are subject to risks and uncertainties, including the risk factors,
and other risks and uncertainties, described in the Company's
filings with the Securities and Exchange Commission, which include
those in the Annual Report on Form 10-K for the year ended December
31, 2010 and the Quarterly Report on Form 10-Q for the quarter
ended September 30, 2011. Forward-looking statements contained in
this press release are made only as of the date hereof, and the
Company undertakes no obligation to update or revise the
forward-looking statements, whether as a result of new information,
future events or otherwise.
CONTACT: ICU Medical, Inc.
Scott E. Lamb, Chief Financial Officer
(949) 366-2183
ICR, LLC
John F. Mills, Senior Managing Director
(310) 954-1105
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024